Home
About us
Team
Portfolio
Stories
ESG & Impact
News
Contact
Fierce Biotech – LUMICKS snags £93M for its molecular tweezers and cell therapy hardware
https://www.fiercebiotech.com/medtech/lumicks-snags-93m-for-its-molecular-tweezers-and-cell-therapy-hardware?mkt_tok=Mjk0LU1RRi0wNTYAAAF8igMUtlBIdahGhfVHfuZPT8bUmAzF958avUNCMmYQPPwgnw3eLOiQb00C2v7YWrzTxX8oHSuJt1FeAy4gqwI9f7Ys6DBkgiBJPLEAkfh24wWuKwQ&mrkid=936965Articles récents
- Lauxera Capital Partners supports Matrix One’s strategic expansion with two acquisitions, strengthening its life sciences software platform
- Lauxera Capital Partners appoints Dr. Oern Stuge as Senior Advisor – Press release
- Lauxera raises over €400 million to support the global expansion of European healthtechs
- Lauxera raises over €400m for its second vintage
- Lauxera tops target for sophomore fund
Commentaires récents
No comments to show.